Safety, Tolerability, and Immunogenicity of a 3-dose Regimen of V114 in Healthy Infants (PNEU-PED-EU-2/V114-026)
Clinical trial NCT04016714 · COMPLETED
Trial details
- NCT number
- NCT04016714
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-08-28
- Primary completion
- 2021-10-29
- Enrollment
- 1191
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.